Dai, Jimin <br/><br/>
[Sestrin 2(SESN2) promotes primary resistance to sorafenib by activating AKT in hepatocellular carcinoma cells].  [electronic resource] 

 -  Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology  May 2018 
 - 427-433 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1007-8738 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis<br/>Carcinoma, Hepatocellular--drug therapy<br/>Cell Line, Tumor<br/>Drug Resistance, Neoplasm<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Nuclear Proteins--metabolism<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Sorafenib--pharmacology